Amlodipine Plus/Minus Atorvastatin for Protection of Arteries
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test the hypothesis that amlodipine plus
atorvastatin given in a single tablet (Caduet), compared with amlodipine alone (Norvasc), has
a stronger effect in protection of arterial structure and function.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Institute of Hypertension
Treatments:
Amlodipine Amlodipine, atorvastatin drug combination Atorvastatin Atorvastatin Calcium